Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Hypertriglyceridemia HELP
Based on 2,788 articles published since 2010
||||

These are the 2788 published articles about Hypertriglyceridemia that originated from Worldwide during 2010-2020.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline Lipid-lowering drugs. 2019

Anonymous2860982. · ·Med Lett Drugs Ther · Pubmed #30845106.

ABSTRACT:

2 Guideline Consensus document on the management of the atherogenic dyslipidaemia of the Spanish Society of Arteriosclerosis. 2017

Ascaso, Juan F / Millán, Jesús / Hernández-Mijares, Antonio / Blasco, Mariano / Brea, Ángel / Díaz, Ángel / Mantilla, Teresa / Pedro-Botet, Juan / Pintó, Xavier / Anonymous2710896. ·Servicio de Endocrinología y Nutrición, CIBERDEM, Hospital Clínico Universitario de Valencia, INCLIVA, Universitat de Valencia, Valencia, España. Electronic address: ascaso@uv.es. · Unidad de Lípidos, Servicio de Medicina Interna, Hospital General Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, Madrid, España. · Servicio de Endocrinología y Nutrición, Hospital Universitario Dr. Peset-FISABIO, Departamento de Medicina, Universidad de Valencia, Valencia, España. · C.S. Delicias Sur, Área Sanitaria III, Zaragoza, España. · Unidad de Lípidos, Servicio de Medicina Interna, Hospital San Pedro, Logroño, España. · Centro de Salud de Bembire, Universidad de León, Membibre, León, España. · Centro de Salud Universitario Prosperidad, Universidad Autónoma de Madrid, Madrid, España. · Unidad de Lípidos y Riesgo Vascular, Servicio de Endocrinología y Nutrición, Hospital del Mar, Universitat Autònoma de Barcelona, Barcelona, España. · Servicio de Medicina Interna, Hospital de Bellvitge, CIBERobn, Fipec, Universidad de Barcelona, Idibell, Hospitalet de Llobregat, Barcelona, España. ·Clin Investig Arterioscler · Pubmed #28185675.

ABSTRACT: Positioning document and summary of recommendations recently published by the Working Group on Atherogenic Dyslipemia of the Spanish Society of Arteriosclerosis and by the European Society of Arteriosclerosis.

3 Guideline The new cholesterol treatment guidelines from the American College of Cardiology/American Heart Association, 2013: what clinicians need to know. 2014

Lim, Tanna H / Orija, Israel B / Pearlman, Brian L / Anonymous4460811 / Anonymous4470811. ·Department of Internal Medicine, Atlanta Medical Center, Atlanta, GA. tannalim@yahoo.com. ·Postgrad Med · Pubmed #25387212.

ABSTRACT: The new American College of Cardiology/American Heart Association blood cholesterol guidelines of 2013 are the first major revision of cholesterol therapy guidance in over a decade. Commonly used low-density lipoprotein cholesterol (LDL-C) target goals have been abrogated in favor of intensity of statin therapy, more in line with data from randomized clinical trials. Four groups of adult patients have been identified from these studies who will most benefit from statins: patients with atherosclerotic cardiovascular disease (ASCVD); patients with primary elevations of LDL-C ≥ 190 mg/dL; diabetic patients between age 40 and 75 years without ASCVD whose LDL-C is between 70 and 189 mg/dL; and patients between age 40 and 75 years without ASCVD or diabetes with LDL-C between 70 and 189 mg/dL and an estimated 10-year ASCVD risk of 7.5% or higher. This last primary prevention group has engendered the most controversy because the newly recommended risk calculator may overestimate risk or the 7.5% threshold may be too low, thereby subjecting too many patients to statins unnecessarily. This review summarizes the latest guidelines and pertinent evidence, and provides case examples to help clinicians familiarize themselves with the new recommendations.

4 Guideline [V Brazilian Guidelines on Dyslipidemias and Prevention of Atherosclerosis]. 2013

Xavier, H T / Izar, M C / Faria Neto, J R / Assad, M H / Rocha, V Z / Sposito, A C / Fonseca, F A / dos Santos, J E / Santos, R D / Bertolami, M C / Faludi, A A / Martinez, T L R / Diament, J / Guimarães, A / Forti, N A / Moriguchi, E / Chagas, A C P / Coelho, O R / Ramires, J A F. · ·Arq Bras Cardiol · Pubmed #24217493.

ABSTRACT: -- No abstract --

5 Guideline Endocrine society releases guidelines on diagnosis and management of hypertriglyceridemia. 2013

Anonymous4600766. · ·Am Fam Physician · Pubmed #23939649.

ABSTRACT: -- No abstract --

6 Guideline Role of omega-3 ethyl ester concentrate in reducing sudden cardiac death following myocardial infarction and in management of hypertriglyceridemia: an Indian consensus statement. 2012

Dalal, J J / Kasliwal, R R / Dutta, A L / Sawhney, J P S / Iyengar, S S / Dani, S / Desai, N / Sathyamurthy, I / Rao, D / Menon, A / Dasbiswas, A / Wander, G S / Chadha, M / Hiremath, M S / Roy, D G / Gupta, V / Shivakadaksham, N. ·Kokilaben Dhirubhai Ambani Hospital, Mumbai, India. jjdalal@hotmail.com ·Indian Heart J · Pubmed #23102390.

ABSTRACT: INTRODUCTION: Sudden cardiac death (SCD) is the most lethal manifestation of heart disease. In an Indian study the SCDs contribute about 10% of the total mortality and SCD post ST elevation myocardial infarction (MI) constitutes for about half of total deaths. OBJECTIVE: Given the limitations of existing therapy there is a need for an effective, easy to use, broadly applicable and affordable intervention to prevent SCD post MI. Leading cardiologists from all over India came together to discuss the potential role of n-3 acid ethyl esters (90%) of eicosapentaenoic acid (EPA) 460 mg & docosahexaenoic acid (DHA) 380 mg in the management of post MI patients and those with hypertriglyceridemia. RECOMMENDATIONS: Highly purified & concentrated omega-3 ethyl esters (90%) of EPA (460 mg) & DHA (380 mg) has clinically proven benefits in improving post MI outcomes (significant 15% risk reduction for all-cause mortality, 20% risk reduction for CVD and 45% risk reduction in SCD in GISSI-Prevenzione trial) and in reducing hypertriglyceridemia, and hence, represent an interesting option adding to the treatment armamentarium in the secondary prevention after MI based on its anti-arrhythmogenic effects and also in reducing hypertriglyceridemia.

7 Guideline Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. 2012

Berglund, Lars / Brunzell, John D / Goldberg, Anne C / Goldberg, Ira J / Sacks, Frank / Murad, Mohammad Hassan / Stalenhoef, Anton F H / Anonymous3890736. ·University of California, Davis, Sacramento, California 95817, USA. ·J Clin Endocrinol Metab · Pubmed #22962670.

ABSTRACT: OBJECTIVE: The aim was to develop clinical practice guidelines on hypertriglyceridemia. PARTICIPANTS: The Task Force included a chair selected by The Endocrine Society Clinical Guidelines Subcommittee (CGS), five additional experts in the field, and a methodologist. The authors received no corporate funding or remuneration. CONSENSUS PROCESS: Consensus was guided by systematic reviews of evidence, e-mail discussion, conference calls, and one in-person meeting. The guidelines were reviewed and approved sequentially by The Endocrine Society's CGS and Clinical Affairs Core Committee, members responding to a web posting, and The Endocrine Society Council. At each stage, the Task Force incorporated changes in response to written comments. CONCLUSIONS: The Task Force recommends that the diagnosis of hypertriglyceridemia be based on fasting levels, that mild and moderate hypertriglyceridemia (triglycerides of 150-999 mg/dl) be diagnosed to aid in the evaluation of cardiovascular risk, and that severe and very severe hypertriglyceridemia (triglycerides of > 1000 mg/dl) be considered a risk for pancreatitis. The Task Force also recommends that patients with hypertriglyceridemia be evaluated for secondary causes of hyperlipidemia and that subjects with primary hypertriglyceridemia be evaluated for family history of dyslipidemia and cardiovascular disease. The Task Force recommends that the treatment goal in patients with moderate hypertriglyceridemia be a non-high-density lipoprotein cholesterol level in agreement with National Cholesterol Education Program Adult Treatment Panel guidelines. The initial treatment should be lifestyle therapy; a combination of diet modification and drug therapy may also be considered. In patients with severe or very severe hypertriglyceridemia, a fibrate should be used as a first-line agent.

8 Guideline Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. 2011

Miller, Michael / Stone, Neil J / Ballantyne, Christie / Bittner, Vera / Criqui, Michael H / Ginsberg, Henry N / Goldberg, Anne Carol / Howard, William James / Jacobson, Marc S / Kris-Etherton, Penny M / Lennie, Terry A / Levi, Moshe / Mazzone, Theodore / Pennathur, Subramanian / Anonymous3190692 / Anonymous3200692 / Anonymous3210692 / Anonymous3220692. ·University of Maryland, MD, USA. ·Circulation · Pubmed #21502576.

ABSTRACT: -- No abstract --

9 Editorial Icosapent ethyl for hypertriglyceridemia: insights from the REDUCE-IT Trial. 2019

Miller, Michael. ·Departments of Medicine, Epidemiology & Public Health, University of Maryland School of Medicine, 110 South Paca Street, Baltimore, MD 21208, USA. ·Future Cardiol · Pubmed #31524535.

ABSTRACT: -- No abstract --

10 Editorial Pitfalls in hypertriglyceridemia induced acute pancreatitis. 2019

Saruç, Murat / Ünal, Hakan Ümit. ·Department of Gastroenterology, Acibadem Mehmet Ali Aydınlar University School of Medicine, İstanbul, Turkey. ·Turk J Gastroenterol · Pubmed #30923032.

ABSTRACT: -- No abstract --

11 Editorial Chylomicrons: When you can't direct the wind, adjust the sail. 2019

Alothman, Latifah / Genest, Jacques. ·Research Institute of the McGill University Health Center, Montreal, Quebec, Canada. · Research Institute of the McGill University Health Center, Montreal, Quebec, Canada. Electronic address: jacques.genest@mcgill.ca. ·Atherosclerosis · Pubmed #30770130.

ABSTRACT: -- No abstract --

12 Editorial Do Elevated Triglycerides Truly Trigger Acute Pancreatitis? 2019

Faghih, Mahya / Singh, Vikesh K. ·Division of Gastroenterology, Pancreatitis Center, Johns Hopkins Medical Institutions, 1830 E. Monument Street, Room 428, Baltimore, MD, 21205, USA. · Division of Gastroenterology, Pancreatitis Center, Johns Hopkins Medical Institutions, 1830 E. Monument Street, Room 428, Baltimore, MD, 21205, USA. vsingh1@jhmi.edu. · Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD, USA. vsingh1@jhmi.edu. ·Dig Dis Sci · Pubmed #30725299.

ABSTRACT:

13 Editorial FISHing for the Miracle of Eicosapentaenoic Acid. 2019

Kastelein, John J P / Stroes, Erik S G. ·From the Academic Medical Center, University of Amsterdam, Amsterdam. ·N Engl J Med · Pubmed #30444682.

ABSTRACT: -- No abstract --

14 Editorial Genetic Variations, Triglycerides, and Atherosclerotic Disease. 2019

Tada, Hayato / Kawashiri, Masa-Aki. ·Division of Cardiovascular and Internal Medicine, Kanazawa University Graduate School of Medical Sciences. ·J Atheroscler Thromb · Pubmed #30078832.

ABSTRACT: -- No abstract --

15 Editorial The concept of severe hypertriglyceridemia and its implications in clinical practice. 2018

Pintó Sala, Xavier / Esteve Luque, Virginia. ·Unidad de Lípidos y Riesgo Vascular, Servicio de Medicina Interna. Hospital Universitario de Bellvitge, CiberObn. Universidad de Barcelona. Fipec. Idibell.. Electronic address: xpinto@bellvitgehospital.cat. · Unidad de Lípidos y Riesgo Vascular, Servicio de Medicina Interna. Hospital Universitario de Bellvitge. ·Clin Investig Arterioscler · Pubmed #30249422.

ABSTRACT: -- No abstract --

16 Editorial Trimming the Fat: Acetyl-CoA Carboxylase Inhibition for the Management of NAFLD. 2018

Imai, Norihiro / Cohen, David E. ·Division of Gastroenterology and Hepatology, Joan & Sanford I. Weill Department of Medicine, Weill Cornell Medical College, New York, NY. ·Hepatology · Pubmed #30076622.

ABSTRACT: -- No abstract --

17 Editorial Triglycerides, Free Fatty Acids, and Glycemic Control: An Unresolved Puzzle. 2018

Rapoport, Micha J / Buchs, Andreas E. ·Department C of Internal Medicine, Assaf Harofeh Medical Center, Zerifin, affiliated with the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department D of Internal Medicine, Assaf Harofeh Medical Center, Zerifin, affiliated with the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. ·Isr Med Assoc J · Pubmed #29911762.

ABSTRACT: -- No abstract --

18 Editorial The metabolic syndrome and the prostate. 2018

Gilling, Peter J. ·Urology, Bay of Plenty District Health Board Clinical School, Tauranga, New Zealand. ·BJU Int · Pubmed #29687952.

ABSTRACT: -- No abstract --

19 Editorial Searching for the Causal Variants of the Association Between Hypertriglyceridemia and the Genome-Wide Association Studies-Derived Signals? Take a Look in the Native American Populations. 2017

Aguilar-Salinas, Carlos A / Sevilla González, Magdalena Del Rocío / Tusie-Luna, María Teresa. ·From the Unidad de Investigación de Enfermedades Metabólicas, Instituto Nacional de Ciencias Médicas y Nutrición, México City, México (C.A.A.-S., M.d.R.S.G.) · Tecnológico de Monterrey, Escuela de Medicina y Ciencias de la Salud, México (C.A.A.-S., M.d.R.S.G.) · Unidad de Biología Molecular y Medicina Genómica, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México (M.T.T.-L.) · and Instituto Nacional de Ciencias Médicas y Nutrición, México City, México (M.T.T.-L.). ·Circ Cardiovasc Genet · Pubmed #29237696.

ABSTRACT: -- No abstract --

20 Editorial Apolipoprotein C-III: The Small Protein With Sizeable Vascular Risk. 2017

Miller, Michael. ·From the Department of Cardiovascular Medicine, University of Maryland School of Medicine and Veterans Affairs Medical Center (VAMC), Baltimore. mmiller@som.umaryland.edu. ·Arterioscler Thromb Vasc Biol · Pubmed #28539488.

ABSTRACT: -- No abstract --

21 Editorial Editorial commentary: Dietary management of familial chylomicronemia syndrome. 2016

Williams, Lauren / Wilson, Don P. ·Cardiovascular Health and Risk Reduction Program, Cook Children's Medical Center, Fort Worth, TX, USA. Electronic address: lauren.williams2@cookchildrens.org. · Cardiovascular Health and Risk Reduction Program, Cook Children's Medical Center, Fort Worth, TX, USA. ·J Clin Lipidol · Pubmed #27206931.

ABSTRACT: -- No abstract --

22 Editorial Significant hypertriglyceridaemia and HDL cholesterol assays. 2016

Twomey, Patrick. ·Clinical Chemistry, St Vincent's University Hospital, Dublin, Ireland p.twomey@svuh.ie. ·Ann Clin Biochem · Pubmed #26960352.

ABSTRACT: -- No abstract --

23 Editorial Hemolyzed blood as a clue to the diagnosis of abdominal pain. 2016

Tariq, Raseen / Khanna, Sahil. ·Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. · Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. khanna.sahil@mayo.edu. ·Intern Emerg Med · Pubmed #26345537.

ABSTRACT: -- No abstract --

24 Editorial Hypertriglyceridemia Associated With Abdominal Obesity: Getting Contributing Factors Into Perspective. 2015

Carpentier, André C. ·From the Division of Endocrinology, Department of Medicine, Centre de recherche du CHUS, Université de Sherbrooke, Sherbrooke, Quebec, Canada. Andre.Carpentier@USherbrooke.ca. ·Arterioscler Thromb Vasc Biol · Pubmed #26399918.

ABSTRACT: -- No abstract --

25 Editorial [Hypertriglyceridemia and LMF 1: Another piece of the puzzle]. 2015

Valdivielso, Pedro. ·Unidad de Lípidos, Hospital Virgen de la Victoria,, Málaga, España; Departamento de Medicina y Dermatología, Instituto de Biomedicina de Málaga (IBIMA), Universidad de Málaga, Málaga, España. Electronic address: valdivielso@uma.es. ·Clin Investig Arterioscler · Pubmed #26398545.

ABSTRACT: -- No abstract --

Next